NTI's standalone ePrescribing solution RxNT eRx achieves Gold Solution Provider status

NewsGuard 100/100 Score

Networking Technology, Inc. (NTI), the leader in electronic healthcare technology, today announced that their standalone eprescribing software product received Gold Solution Provider status from Surescripts®. NTI's standalone ePrescribing solution RxNT eRx has achieved Gold Solution Provider status placing their standalone eprescribing solution into an elite group of certified products for the fourth year in a row.

“Looking forward, we see the company continuing to be an eHealth industry leader and our eprescribing technology continue to evolve to meet the expectations of our clients and business partners.”

"Since May 1999 NTI has been a leader in the advancement of ePrescribing technology," states Randy Boldyga, CEO of RxNT. "Looking forward, we see the company continuing to be an eHealth industry leader and our eprescribing technology continue to evolve to meet the expectations of our clients and business partners."

Gold Solution Provider status is granted by Surescripts to vendors with software products that have gone beyond Surescripts baseline product certification to meet benchmarks that demonstrate a higher level of commitment to eprescribing.

Source:

Networking Technology, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Top minds in multiple sclerosis to speak at CMSC 38th Annual Meeting